Lundbeck said to express interest in buying Xeris Biopharma

Lundbeck is said to have expressed interest in acquiring Xeris Biopharma, according to a report citing unnamed sources. No terms or confirmation from either company were disclosed.

Detected & updated continuously · Source: Nebula